Non selective beta-blockers prevent PHT-related complications occurrence in HCC patients with esophageal varices treated by TACE
Authors:
- 13 November 2024
- journal article
- research article
- Published by Elsevier in Clinics and Research in Hepatology and Gastroenterology
- Vol. 49 (1) , 102496
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Portal hypertension and variceal bleeding in patients with liver cancer: Evidence gaps for prevention and managementHepatology, 2023
- BCLC strategy for prognosis prediction and treatment recommendation: The 2022 updateJournal of Hepatology, 2021
- Virologic control and severity of liver disease determine survival after radiofrequency ablation of hepatocellular carcinoma on cirrhosisDigestive and Liver Disease, 2019
- Clinical states of cirrhosis and competing risksJournal of Hepatology, 2018
- Portal hypertension is associated with poor outcome of transarterial chemoembolization in patients with hepatocellular carcinomaEuropean Radiology, 2017
- Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular CarcinomaDigestive Diseases and Sciences, 2016
- Expanding consensus in portal hypertensionJournal of Hepatology, 2015
- Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta‐analysisHepatology, 2015
- Rebleeding prophylaxis improves outcomes in patients with hepatocellular carcinoma. A multicenter case-control studyHepatology, 2013
- Ascites in patients with hepatocellular carcinoma: prevalence, associated factors, prognostic impact, and staging strategyHepatology International, 2012